The MENDS2 trial found that dexmedetomidine, when used for light sedation, had outcomes similar to those for propofol.
ABSTRACT & COMMENTARY
Dexmedetomidine Compared to Propofol for Sedation in Mechanically Ventilated Patients with Sepsis
August 1, 2021